Melanotan II and PT-141 (bremelanotide) are both melanocortin receptor peptides derived from alpha-MSH, but they differ significantly in receptor selectivity and research applications.
Melanocortin Receptor System
The melanocortin receptor family (MC1R through MC5R) mediates diverse physiological functions. Melanotan II is a non-selective agonist that binds to multiple subtypes, particularly MC1R (pigmentation) and MC4R. PT-141 was designed to preferentially activate MC4R and MC3R while reducing MC1R-mediated effects.
Structural Relationship
PT-141 is a metabolite of Melanotan II. The cyclic lactam structure of MT-II is preserved in PT-141 but with modifications that alter receptor binding selectivity. This metabolic relationship explains their overlapping but distinct pharmacological profiles.
Research Context
Melanotan II research focuses on pigmentation pathways and UV-protective melanogenesis. PT-141 research centers on central MC4R-mediated pathways. Both peptides have been studied in multiple preclinical models.